Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Hypertension. 1987;9:198-203

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vincent, H. H.
Right arrow Articles by Schalekamp, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vincent, H. H.
Right arrow Articles by Schalekamp, M. A.

Hypertension, Vol 9, 198-203, Copyright © 1987 by American Heart Association

ARTICLES

Is beta 1-antagonism essential for the antihypertensive action of beta- blockers? [published erratum appears in Hypertension 1987 May;9(5):521]

HH Vincent, AJ Man in 't Veld, F Boomsma, FH Derkx and MA Schalekamp

Both nonselective beta-blockers and beta 1-selective blockers are effective antihypertensive agents. beta 1-Blockade generally is considered to be responsible for their antihypertensive action, whereas beta 2-blockade is regarded as undesirable. These common assumptions notwithstanding, the mechanism by which beta-blockers lower blood pressure remains unknown. To examine the possibility that beta 2- blockade may contribute to the antihypertensive action of beta-blocker therapy, we studied the cardiovascular effects of compound ICI 118551, a beta 2-selective blocker. First, we showed that 50 mg t.i.d. orally is a beta 2-selective dose. In contrast to propranolol, 80 mg t.i.d., or atenolol, 100 mg once a day, 50 mg of ICI 118551 t.i.d. failed to block beta 1-mediated inotropic stimulation and stimulation of renin by isoproterenol. We then performed a double-blind, placebo-controlled trial in patients with mild essential hypertension to compare this compound with propranolol, 80 mg t.i.d., and showed that ICI 118551 significantly decreased systolic and diastolic blood pressure. This antihypertensive effect was demonstrated by direct as well as by indirect blood pressure measurements. Thus, contrary to prevailing thought, beta 2-blockade has an antihypertensive effect independent of, and distinct from, beta 1-blockade.


This article has been cited by other articles:


Home page
 HypertensionHome page
D. Wenzel, R. Knies, M. Matthey, A. M. Klein, J. Welschoff, V. Stolle, P. Sasse, W. Roll, J. Breuer, and B. K. Fleischmann
{beta}2-Adrenoceptor Antagonist ICI 118,551 Decreases Pulmonary Vascular Tone in Mice via a Gi/o Protein/Nitric Oxide-Coupled Pathway
Hypertension, July 1, 2009; 54(1): 157 - 163.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. D. Potts, A. M. Allen, J. Horiuchi, and R. A. L. Dampney
Does angiotensin II have a significant tonic action on cardiovascular neurons in the rostral and caudal VLM?
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1392 - R1402.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
U. Poller, B. Fuchs, A. Gorf, J. Jakubetz, J. Radke, K. Ponicke, and O.-E. Brodde
Terbutaline-induced desensitization of human cardiac {beta}2-adrenoceptor-mediated positive inotropic effects: attenuation by ketotifen
Cardiovasc Res, October 1, 1998; 40(1): 211 - 222.
[Abstract] [Full Text] [PDF]


Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1987 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.